We are live on ! Find out more
Los Angeles Capital Management

Los Angeles Capital Management Portfolio holdings

AUM $25.4B
1-Year Est. Return 38.46%
This Fund
S&P 500
This Quarter Est. Return
+14.69%
1 Year Est. Return
+38.46%
3 Year Est. Return
+154.38%
5 Year Est. Return
+223.79%
10 Year Est. Return
+923.25%
AUM
$26.8B
AUM Growth
+$3.21B
Cap. Flow
+$169M
Cap. Flow %
0.63%
Top 10 Hldgs %
33.69%
Holding
1,279
New
177
Increased
369
Reduced
457
Closed
160

Top Buys

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$161M
2
TGT icon
Target
TGT
+$149M
3
AMGN icon
Amgen
AMGN
+$142M
4
ROST icon
Ross Stores
ROST
+$120M
5
MMM icon
3M
MMM
+$106M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$123M
2
LLY icon
Eli Lilly
LLY
+$110M
3
CSCO icon
Cisco
CSCO
+$109M
4
ADBE icon
Adobe
ADBE
+$98.2M
5
NEM icon
Newmont
NEM
+$94.7M

Sector Composition

Rank Sector Weight
1 Technology 34.52%
2 Consumer Discretionary 14.2%
3 Financials 13.06%
4 Industrials 10.11%
5 Communication Services 9.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBRA icon
1101
Sabra Healthcare REIT
SBRA
$5.16B
$184K ﹤0.01%
12,926
FOLD
1102
DELISTED
Amicus Therapeutics
FOLD
$184K ﹤0.01%
12,976
PCG icon
1103
PG&E
PCG
$38.3B
$183K ﹤0.01%
+10,154
New +$171K
HR icon
1104
Healthcare Realty
HR
$6.58B
$183K ﹤0.01%
10,598
-74,995
-88% -$1.15M
WSBF icon
1105
Waterstone Financial
WSBF
$378M
$170K ﹤0.01%
+11,965
New +$141K
RLJ icon
1106
RLJ Lodging Trust
RLJ
$1.66B
$168K ﹤0.01%
+14,320
New +$149K
AGEN
1107
Agenus
AGEN
$311M
$166K ﹤0.01%
10,041
+4,900
+95% +$81.2K
CERS icon
1108
Cerus
CERS
$546M
$166K ﹤0.01%
76,944
+90
+0.1% +$148
PACB icon
1109
Pacific Biosciences
PACB
$345M
$160K ﹤0.01%
16,359
HIMS icon
1110
Hims & Hers Health
HIMS
$6.99B
$158K ﹤0.01%
17,801
+268
+2% +$1.98K
RLAY icon
1111
Relay Therapeutics
RLAY
$4.4B
$122K ﹤0.01%
11,089
MAX icon
1112
MediaAlpha
MAX
$787M
$121K ﹤0.01%
10,865
HCAT icon
1113
Health Catalyst
HCAT
$135M
$108K ﹤0.01%
+11,670
New +$95.4K
NU icon
1114
Nu Holdings
NU
$65.5B
$106K ﹤0.01%
12,782
+1,579
+14% +$12.8K
ADPT icon
1115
Adaptive Biotechnologies
ADPT
$4.02B
$106K ﹤0.01%
21,632
FCEL icon
1116
FuelCell Energy
FCEL
$1.73B
$81.3K ﹤0.01%
1,693
MPT
1117
Medical Properties Trust
MPT
$2.42B
$65.3K ﹤0.01%
+13,290
New +$65.1K
NVTA
1118
DELISTED
Invitae Corporation
NVTA
$6.6K ﹤0.01%
10,532
-27,260
-72% -$16.3K
ACA icon
1119
Arcosa
ACA
$7.12B
-16,236
Closed -$1.17M
ACMR icon
1120
ACM Research
ACMR
$5.66B
-66,026
Closed -$1.2M
ADM icon
1121
Archer Daniels Midland
ADM
$38.4B
-20,545
Closed -$1.55M
AER icon
1122
AerCap
AER
$23.6B
-10,529
Closed -$660K
AGNC icon
1123
AGNC Investment
AGNC
$12.9B
-14,369
Closed -$136K
ALGT icon
1124
Allegiant Air
ALGT
$2.31B
-6,463
Closed -$497K
ALHC icon
1125
Alignment Healthcare
ALHC
$2.8B
-92,369
Closed -$641K

Similar funds

Los Angeles Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Los Angeles Capital Management held 1,279 positions worth $26.8B, up 14% from $23.6B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Los Angeles Capital Management's Q4 2023 filing shows 177 new, 369 increased, 457 reduced and 160 closed positions. Its largest new stake was Capital One: 352,866 shares worth $46.3M. The largest sale was Visa, an estimated $123M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Los Angeles Capital Management's largest Q4 2023 buy was Capital One: 352,866 shares worth $46.3M.
  • Los Angeles Capital Management added most to Starbucks in Q4 2023, an estimated $161M increase.
  • Los Angeles Capital Management's biggest Q4 2023 reduction was Visa, cutting an estimated $123M.
  • Los Angeles Capital Management fully exited Brown-Forman Class B in Q4 2023, selling an estimated $45M.
  • Los Angeles Capital Management's ten largest holdings make up 34% of its $26.8B portfolio in Q4 2023.
  • Los Angeles Capital Management opened 177 new positions and closed 160 in Q4 2023.
  • Los Angeles Capital Management's portfolio value rose 14% quarter-over-quarter to $26.8B.

Based on Los Angeles Capital Management's 13F filing for Q4 2023, filed 6 Feb 2024.